000			02119 a2200601 4500
005			20250515234935.0
264		0	_c20110414
008			201104s 0 0 eng d
022			_a1942-0870
024	7		_a10.4161/mabs.2.5.13054 _2doi
040			_aNLM _beng _cNLM
100	1		_aMilenic, Diane E
245	0	0	_aTargeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials. _h[electronic resource]
260			_bmAbs _c
300			_a550-64 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xchemistry
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Agents _xchemistry
650	0	4	_aCell Line, Tumor
650	0	4	_aClinical Trials as Topic
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHT29 Cells
650	0	4	_aHumans
650	0	4	_aImmunoconjugates _xchemistry
650	0	4	_aIndium Radioisotopes _xadministration & dosage
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aInjections, Intravenous
650	0	4	_aIsothiocyanates _xchemistry
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPentetic Acid _xanalogs & derivatives
650	0	4	_aPositron-Emission Tomography
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aRadionuclide Imaging
650	0	4	_aReceptor, ErbB-2 _xantagonists & inhibitors
650	0	4	_aTissue Distribution
650	0	4	_aTrastuzumab
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aWong, Karen J
700	1		_aBaidoo, Kwamena E
700	1		_aNayak, Tapan K
700	1		_aRegino, Celeste A S
700	1		_aGarmestani, Kayhan
700	1		_aBrechbiel, Martin W
773	0		_tmAbs _gvol. 2 _gno. 5 _gp. 550-64
856	4	0	_uhttps://doi.org/10.4161/mabs.2.5.13054 _zAvailable from publisher's website
999			_c20053079 _d20053079